11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome
Open accessThe DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Abstract
Context: Androgen excess is a defining feature of polycystic ovary syndrome (PCOS), but the exact origin of hyperandrogenemia remains a matter of debate. Recent studies have highlighted the importance of the 11-oxygenated C19 steroid pathway to androgen metabolism in humans. In this study, we analyzed the contribution of 11-oxygenated androgens to androgen excess in women with PCOS. Methods: One hundred fourteen women with PCOS and 49 healthy control subjects underwent measurement of serum androgens by liquid chromatography-tandem mass spectrometry. Twenty-four–hour urinary androgen excretion was analyzed by gas chromatography-mass spectrometry. Fasting plasma insulin and glucose were measured for homeostatic model assessment of insulin resistance. Baseline demographic data, including body mass index, were recorded. Results: As expected, serum concentrations of the classic androgens testosterone (P < 0.001), androstenedione (P < 0.001), and dehydroepiandrosterone (P < 0.01) were significantly increased in PCOS. Mirroring this, serum 11-oxygenated androgens 11β-hydroxyandrostenedione, 11-ketoandrostenedione, 11β-hydroxytestosterone, and 11-ketotestosterone were significantly higher in PCOS than in control subjects, as was the urinary 11-oxygenated androgen metabolite 11β-hydroxyandrosterone. The proportionate contribution of 11-oxygenated to total serum androgens was significantly higher in patients with PCOS compared with control subjects [53.0% (interquartile range, 48.7 to 60.3) vs 44.0% (interquartile range, 32.9 to 54.9); P < 0.0001]. Obese (n = 51) and nonobese (n = 63) patients with PCOS had significantly increased 11-oxygenated androgens. Serum 11β-hydroxyandrostenedione and 11-ketoandrostenedione correlated significantly with markers of insulin resistance. Conclusions: We show that 11-oxygenated androgens represent the majority of circulating androgens in women with PCOS, with close correlation to markers of metabolic risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“11KA4 is the next most abundant 11-oxygenated androgen precursor in circulation (Table 2) [39,41,68,69,289].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [41]
The cited source says what the claim attributes to it.
In the citing paper
“While the levels of 11-oxygenated androgens and their precursors have been shown to be significantly elevated in patients with polycystic ovary syndrome (PCOS) and 21-hydroxylase deficiency [41,69], one study reported that the circulating levels of 11KT were also higher than that of testosterone in a healthy female control group (BMI 21.2–26.1 kg/m2) [41].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [41]
The cited source says what the claim attributes to it.
In the citing paper
“The significant levels of 11KA4 measured in the serum of healthy premenopausal woman (O'Reilly et al., 2016) supports the involvement of peripheral tissue such as the kidney, especially considering that the adrenal expresses only low levels of HSD11B2 (Coulter et al., 1999).”
From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as O'Reilly et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“Notably, the androgen profile in endometriosis, as described in our study, is different from that reported for PCOS.13”
From Steroid hormone profiling reveals altered adrenal androgen production in endometriosis (2026) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“In PCOS, median concentrations of 11OHA4, and 11KA4, as reported by O’Reilly et al., are 31.7 nmol/L and 13.4 nmol/L, respectively, and are increased relative to healthy controls.”
From Steroid hormone profiling reveals altered adrenal androgen production in endometriosis (2026) · cites this paper as [13]
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
Conway, G., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Franks, S., Gambineri, A., Kelestimur, F., Macut, D., Micic, D., Pasquali, R., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0253 · Cited by 676
Arlt, W., Walker, E. A., Draper, N., Ivison, H. E., Ride, J. P., Hammer, F., Chalder, S. M., Borucka-Mankiewicz, M., Hauffa, B. P., Malunowicz, E. M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16503-3 · Cited by 345
Self-citationO'Reilly, M. W., Taylor, A. E., Crabtree, N. J., Hughes, B. A., Capper, F., Crowley, R. K., Stewart, P. M., Tomlinson, J. W., & Arlt, W. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3399 · Cited by 283
Self-citationTurcu, A. F., Nanba, A. T., Chomic, R., Upadhyay, S. K., Giordano, T. J., Shields, J. J., Merke, D. P., Rainey, W. E., & Auchus, R. J. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1181 · Cited by 231
Rege, J., Nakamura, Y., Satoh, F., Morimoto, R., Kennedy, M. R., Layman, L. C., Honma, S., Sasano, H., & Rainey, W. E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2912 · Cited by 227
Storbeck, K.-H., Bloem, L. M., Africander, D., Schloms, L., Swart, P., & Swart, A. C. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.07.006 · Cited by 198
Self-citationQuinkler, M., Sinha, B., Tomlinson, J. W., Bujalska, I. J., Stewart, P. M., & Arlt, W. (2004) · Journal of Endocrinology · doi:10.1677/joe.1.05762 · Cited by 190
Self-citation5 α-reductase activity in polycystic ovary syndrome
Stewart, P. M., Edwards, C. R. W., Shackleton, C. H. L., & Beastall, G. H. (1990) · The Lancet · doi:10.1016/0140-6736(90)90664-q · Cited by 189
Understanding androgen action in adipose tissue
O’Reilly, M. W., House, P. J., & Tomlinson., J. W. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.04.008 · Cited by 180
Self-citationLC–MS/MS analysis of steroids in the clinical laboratory
Keevil, B. G. (2016) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2016.04.009 · Cited by 149
Pretorius, E., Africander, D. J., Vlok, M., Perkins, M. S., Quanson, J., & Storbeck, K.-H. (2016) · PLOS ONE · doi:10.1371/journal.pone.0159867 · Cited by 148
Self-citationA new dawn for androgens: novel lessons from 11-oxygenated C19 steroids
Pretorius, E., Arlt, W., & Storbeck, K.-H. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.08.014 · Cited by 142
Self-citationSwart, A. C., Schloms, L., Storbeck, K.-H., Bloem, L. M., Toit, T. D., Quanson, J. L., Rainey, W. E., & Swart, P. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.04.010 · Cited by 125
Self-citationDefining Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Challenging Perspective
Pasquali, R., Zanotti, L., Fanelli, F., Mezzullo, M., Fazzini, A., Labate, A. M. M., Repaci, A., Ribichini, D., & Gambineri, A. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4009 · Cited by 124
Increased 5α-Reductase Activity and Adrenocortical Drive in Women with Polycystic Ovary Syndrome
Vassiliadi, D. A., Barber, T. M., Hughes, B. A., McCarthy, M. I., Wass, J. A. H., Franks, S., Nightingale, P., Tomlinson, J. W., Arlt, W., & Stewart, P. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0837 · Cited by 110
Self-citationWeight Loss Increases 11β-Hydroxysteroid Dehydrogenase Type 1 Expression in Human Adipose Tissue
Tomlinson, J., Moore, J. S., Clark, P., Holder, G., Shakespeare, L., & Stewart, P. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031376 · Cited by 103
Mongraw‐Chaffin, M., Anderson, C. A. M., Allison, M., Ouyang, P., Szklo, M., Vaidya, D. M., Woodward, M., & Golden, S. H. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2934 · Cited by 102
11-Ketotestosterone Is a Major Androgen Produced in Human Gonads
Imamichi, Y., Yuhki, K.-I., Orisaka, M., Kitano, T., Mukai, K., Ushikubi, F., Taniguchi, T., Umezawa, A., Miyamoto, K., & Yazawa, T. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2311 · Cited by 96
Yazawa, T., Uesaka, M., Inaoka, Y., Mizutani, T., Sekiguchi, T., Kajitani, T., Kitano, T., Umezawa, A., & Miyamoto, K. (2008) · Endocrinology · doi:10.1210/en.2007-1015 · Cited by 95
Wang, L., Li, S., Zhao, A., Tao, T., Mao, X., Zhang, P., & Liu, W. (2012) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2012.02.003 · Cited by 82
Büttler, R. M., Martens, F., Fanelli, F., Pham, H. T., Kushnir, M. M., Janssen, M. J. W., Owen, L., Taylor, A. E., Soeborg, T., Blankenstein, M. A., et al. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.242859 · Cited by 76
Self-citationQuanson, J. L., Stander, M. A., Pretorius, E., Jenkinson, C., Taylor, A. E., & Storbeck, K.-H. (2016) · Journal of Chromatography B · doi:10.1016/j.jchromb.2016.07.024 · Cited by 74
Self-citationDevelopment of a Novel Cell Based Androgen Screening Model
Campana, C., Rege, J., Turcu, A. F., Pezzi, V., Gomez-Sanchez, C. E., Robins, D. M., & Rainey, W. E. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.11.005 · Cited by 73
Blouin, K., Blanchette, S., Richard, C., Dupont, P., Luu-The, V., & Tchernof, A. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00312.2004 · Cited by 67
Nada, S. E., Thompson, R. C., & Padmanabhan, V. (2010) · Endocrinology · doi:10.1210/en.2010-0666 · Cited by 56
Carmina, E., Stanczyk, F. Z., Chang, L., Miles, R. A., & Løbo, R. A. (1992) · Fertility and Sterility · doi:10.1016/s0015-0282(16)55152-8 · Cited by 54
Torchen, L. C., Idkowiak, J., Fogel, N. R., O'Neil, D. M., Shackleton, C. H. L., Arlt, W., & Dunaif, A. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3926 · Cited by 49
Self-citationPrenatal androgen excess programs metabolic derangements in pubertal female rats
Yan, X., Dai, X., Wang, J., Zhao, N., Cui, Y., & Liu, J. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0577 · Cited by 47
Chadwick, C. A., Owen, L. J., & Keevil, B. G. (2005) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/000456305774538175 · Cited by 36
Owen, E. J., Holownia, P., Conway, G. S., Jacobs, H. S., & Honour, J. W. (1992) · PubMed · Cited by 24
Owen, E. J., Holownia, P., Conway, G. S., Jacobs, H. S., & Honour, J. W. (1992) · Fertility and Sterility · doi:10.1016/s0015-0282(16)55317-5 · Cited by 23
Studies to confirm the source of 11ß-hydroxyandrostenedione
Holownia, P., Owen, E. J., Conway, G. S., Round, J. M., & Honour, J. W. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90441-k · Cited by 21
Cited by
Witchel, S. F., Oberfield, S. E., & Peña, A. S. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00078 · Cited by 653
Circulating Testosterone as the Hormonal Basis of Sex Differences in Athletic Performance
Handelsman, D. J., Hirschberg, A. L., & Bermon, S. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00020 · Cited by 594
Polycystic Ovarian Syndrome: Correlation Between Hyperandrogenism, Insulin Resistance and Obesity.
Zeng, X., Xie, Y.-J., Liu, Y.-T., Long, S.-L., & Mo, Z.-C. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.11.003 · Cited by 525
Martin, K. A., Chang, R. J., Ehrmann, D. A., Ibanez, L., Lobo, R. A., Rosenfield, R. L., Shapiro, J., Montori, V. M., & Swiglo, B. A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2437 · Cited by 512
Ibáñez, L., Oberfield, S. E., Witchel, S., Auchus, R. J., Chang, R. J., Codner, E., Dabadghao, P., Darendeliler, F., Elbarbary, N. S., Gambineri, A., et al. (2017) · Hormone Research in Paediatrics · doi:10.1159/000479371 · Cited by 463
Metadata
- Authors
- O’Reilly, M. W., Kempegowda, P., Jenkinson, C., Taylor, A. E., Quanson, J. L., Storbeck, K.-H., & Arlt, W.
- Affiliations
- University of Birmingham (GB)
- Stellenbosch University (ZA)
- University Hospitals Birmingham NHS Foundation Trust (GB)
- Corresponding author
- Arlt, Wiebke
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2016-11-30
- Volume
- 102
- Issue
- 3
- Pages
- 840-848
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC5460696
- OpenAlex
- W2557976244
- Cited by
- 267
- References
- 36
- Citations by year
- 2026: 26 · 2025: 28 · 2024: 24 · 2023: 23 · 2022: 29 · 2021: 38 · 2020: 36 · 2019: 29 · 2018: 25 · 2017: 8
- FWCI
- 27.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by)
- Funders
- Wellcome Trust (099909, 092283)
- Newton Fund
- National Institute for Health and Care Research (ACF-2013-09-001)
- Royal Society
- Academy of Medical Sciences (NAF004\1002)
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Keywords
- polycystic ovary syndrome, hyperandrogenism, hyperandrogenemia, 11β-hydroxyandrostenedione, 11-ketoandrostenedione, 11β-hydroxytestosterone, 11-ketotestosterone, androgen metabolism, insulin resistance, obesity, testosterone, androstenedione, dehydroepiandrosterone
- MeSH terms
- Adult, Androgens, Androstenedione, Androstenes, Blood Glucose, Chromatography, Liquid, Dehydroepiandrosterone, Female, Humans, Hydroxytestosterones, Insulin, Insulin Resistance, Gas Chromatography-Mass Spectrometry, Obesity, Polycystic Ovary Syndrome, Testosterone, Case-Control Studies, Hyperandrogenism, Tandem Mass Spectrometry, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.